Major depressive disorder (MDD) afflicts millions globally, with conventional treatments often proving lacking. This has fueled the exploration of alternative therapeutic approaches. Among these, ketamine has emerged as a promising candidate for MDD treatment. Ketamine is a hallucinogenic agent with